Michael C. Donegan - 12 Apr 2023 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role: Prin. Fin. and Acctg. Officer
Signature: /s/ Michael C. Donegan
Issuer symbol: TXMD
Transactions as of: 12 Apr 2023
Net transactions value: $0
Form type: 4
Filing time: 14 Apr 2023, 19:17:22 UTC
Previous filing: 23 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXMD	Common Stock	Options Exercise	$0	+50,000	+422%	$0.000000	61,853	12 Apr 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TXMD	Restricted Stock Units	Options Exercise	$0	-50,000	-100%	$0.000000^*	0	12 Apr 2023	Common Stock	50,000	$0.000000	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of issuer common stock upon settlement. On April 12, 2023, the reporting person received 50,000 shares of issuer common stock in settlement of restricted stock units (RSUs).
F2	Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in full on March 31, 2023.